Pharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia
Research output: Contribution to journal › Editorial
Colleges, School and Institutes
- Cancer Bioinfomatics Group, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Within the hematopoietic system, core binding factor beta (CBFβ) normally forms a complex with the master hematopoietic regulator, RUNX1 (1) and stabilizes its binding to DNA (2).
|Number of pages||5|
|Journal||Stem Cell Investigation|
|Publication status||Published - 30 Sep 2018|